SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Instagram Outage Disrupts Thousands of U.S. Users 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Chinese humanoid robot maker AgiBot is preparing for a major initial public offering (IPO) in Hong Kong next year, targeting a valuation between HK$40 billion and HK$50 billion (approximately $5.14–$6.4 billion), according to insider sources. The Shanghai-based startup, founded in 2023 by ex-Huawei engineers Deng Taihua and Peng Zhihui, has quickly risen to prominence amid China’s push to expand its robotics and automation capabilities.
AgiBot has appointed China International Capital Corp (CICC) and CITIC Securities as lead underwriters, with Morgan Stanley joining the effort recently. The firm aims to file a preliminary prospectus early next year and potentially list publicly by the third quarter of 2026, sources said. The IPO could involve the issuance of 15%–25% of its shares, though final details are still subject to change. As of March, PitchBook valued the company at $2.07 billion.
The company’s rapid growth has been fueled by strong investor backing, including Tencent, HongShan Capital Group (HSG), LG Electronics, Mirae Asset, BYD, and Hillhouse Investment. In August, AgiBot secured a multi-million yuan partnership with Fulin Precision Engineering, deploying nearly 100 of its Yuanzheng humanoid robots in factory operations.
AgiBot develops humanoid robots and AI-powered data collection tools under its Yuanzheng and Lingxi product lines, focusing on applications in manufacturing, logistics, and service automation. At its Shanghai training center, robots are trained for complex daily tasks like folding clothes, making coffee, and cleaning.
The company gained significant attention earlier this year when President Xi Jinping visited its facilities, showcasing the government’s support for the domestic robotics industry. Its upcoming IPO follows Ubtech Robotics’ 2023 Hong Kong debut, whose stock has surged over 150% this year, and comes as Unitree Robotics plans its own IPO on Shanghai’s STAR Market at a potential 50 billion yuan valuation.
With over 270 IPO filings in Hong Kong this year, the city has reclaimed its status as the world’s leading exchange by combined IPO and secondary listings, raising nearly $24 billion—more than double the total funds raised in 2024.
AgiBot’s planned public offering signals China’s growing ambition to lead the global humanoid robotics race, backed by strong capital, advanced AI integration, and government endorsement.
